Latest Breaking News On - Ken zaslav - Page 3 : comparemela.com

CartiHeal succeeds in clinical trial for cartilage treatment CartiHeal is on a Breakthrough Therapy fast track for FDA approval, and US company Bioventus has an option to acquire it. Israeli company CartiHeal has announced success in a clinical trial of its treatment for knee cartilage damaged either by injury or by arthritis. The company reported that its cartilage substitute product was more successful than the currently used treatments. The trial involved 251 patients, and was conducted over two years. Among the investors in CartiHeal are Elron Electronic Industries Ltd. (TASE: ELRN), with a holding of 27%, Accelmed, headed by Dr. Uri Geiger, venture capital firms aMoon, Peregrine Ventures, Johnson & Johnson Innovation, and Access Medical. The company s technology originated at Ben Gurion University of the Negev, which also holds shares in the company through its technology transfer arm. The company was founded in the Incentive technology incubator, owned by Peregrine Ventures.

Ken zaslavCartiheal agiliNir altschulerBen gurion university of the negevElron electronic industries ltdDrug administrationInternational cartilage repair societyElron electronic industriesUri geigerPeregrine venturesJohnson innovationBen gurion universityBreakthrough therapy approvalDaily livingBreakthrough designationநீர் அலட்ஸ்சுலேர்